Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance
- 21 April 2005
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (7) , 989-993
Abstract
Hemodialysis (HD) catheter occlusion is a common cause of poor blood flow and inadequate dialysis. In order to address this problem in our pediatric dialysis unit, we elected to use short (2-h) infusions of low-dose recombinant tissue plasminogen activator (rtPA) for thrombolysis of occluded catheters. Catheters meeting diagnostic criteria for thrombosis were infused with 2.5 mg rtPA in 25 ml 0.9 normal saline over 2 h prior to dialysis. Retrospective data collection was carried out to assess the success of this procedure. Variables assessed included blood flow (Qb), transmembrane pressure (TMP) and venous pressure (VP) before and after rtPA infusion. Seven catheter thromboses in six patients were successfully treated with rtPA; there were significant improvements in Qb ( p p p 200 ml/min. No adverse events were observed. Low-dose rtPA infusion is safe and effective for catheter thrombolysis in outpatient pediatric HD patients. It may serve as an alternative method of administration to local instillation and may be used to restore patency before resorting to surgical revisions.Keywords
This publication has 28 references indexed in Scilit:
- The Efficacy and Safety of Reteplase for Thrombolysis of Hemodialysis Catheters at a Community and Academic Regional Medical CenterNephron Clinical Practice, 2004
- The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusionsJournal of Vascular Surgery, 2003
- Alteplase Versus Urokinase for Occluded Hemodialysis CathetersAnnals of Pharmacotherapy, 2003
- The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort studyThe Journal of Pediatrics, 2001
- A prospective study of vascular access infections at seven outpatient hemodialysis centersAmerican Journal of Kidney Diseases, 2001
- Efficacy of tissue plasminogen activator administration on patency of hemodialysis access cathetersAmerican Journal of Kidney Diseases, 2000
- Recombinant tissue plasminogen activator is a useful alternative to heparin in priming Quinton PermcathAmerican Journal of Kidney Diseases, 2000
- Hemodialysis vascular access: Entering a new eraAmerican Journal of Kidney Diseases, 1999
- Reducing the risk of hemodialysis accessAmerican Journal of Kidney Diseases, 1999
- Use of Dacron Cuffed Silicone Catheters as Long-Term Hemodialysis AccessASAIO Journal, 1992